Institutional Ownership
Shareholders
| Shareholder | Holders | Value ($MM) | % O/S | Shares |
|---|---|---|---|---|
| Institution | 292 | 795.80 | 59.53 | 84,196,301 |
| Mutual Fund | 271 | 302.08 | 21.90 | 30,684,808 |
| Insider | 18 | 4.34 | 0.34 | 476,434 |
Rotation
| Shareholder | Holders | Value Chg ($MM) | % O/S | Share Change |
|---|---|---|---|---|
| Buyers | 120 | 86.89 | 6.49 | 9,174,907 |
| Sellers | 128 | -61.29 | 4.69 | -6,627,603 |
| Net | 25.60 | 1.80 | 2,547,304 |
Concentration
| Value ($MM) | % O/S | Shares | |
|---|---|---|---|
| Total Inst. | 998.90 | 77.11 | 109,063,174 |
| Top 10 Inst. | 622.49 | 48.95 | 69,231,067 |
| Top 20 Inst. | 745.84 | 58.21 | 82,336,876 |
| Top 50 Inst. | 891.81 | 69.13 | 97,780,067 |
Style
| Holders | Value ($MM) | % Inst Shares | Shares | |
|---|---|---|---|---|
| Growth | 68 | 144.38 | 10.79 | 15,267,794 |
| Aggressive Growth | 5 | 4.60 | 0.34 | 486,498 |
| Core Growth | 51 | 95.16 | 7.11 | 10,059,209 |
| Growth | 12 | 44.62 | 3.34 | 4,722,087 |
| Income | 6 | 3.59 | 0.27 | 383,684 |
| Income Value | 3 | 3.39 | 0.25 | 358,718 |
| Yield | 3 | 0.20 | 0.02 | 24,966 |
| Index | 32 | 286.09 | 21.39 | 30,250,098 |
| Other | 95 | 298.17 | 22.29 | 31,524,264 |
| Broker Dealer | 21 | 37.81 | 2.83 | 4,003,142 |
| GARP | 34 | 125.12 | 9.34 | 13,204,706 |
| Hedge Fund | 38 | 133.78 | 10.01 | 14,161,390 |
| Specialty | 2 | 1.46 | 0.11 | 155,026 |
| Value | 38 | 43.79 | 3.27 | 4,624,838 |
| Core Value | 30 | 36.98 | 2.76 | 3,908,560 |
| Deep Value | 8 | 6.81 | 0.51 | 716,278 |
Location: Global Region
| Holders | % O/S | Shares | Share Value | |
|---|---|---|---|---|
| North America | 242 | 67.47 | 95,431,301 | 869,411,200 |
| Europe | 54 | 9.30 | 13,148,459 | 124,615,572 |
| Asia / Pacific | 14 | 0.36 | 503,837 | 5,056,803 |
| Africa | 1 | 0.01 | 9,795 | 81,984 |
Top Holders
| Holder | Shares Held | % O/S | Share Change | Filing Date |
|---|---|---|---|---|
| Biogen Inc | 24,420,157 | 17.27 | 24,420,157 | 4/8/20 |
| BlackRock Institutional Trust Company, N.A. | 8,638,013 | 6.11 | -358,086 | 9/30/20 |
| The Vanguard Group, Inc. | 8,126,559 | 5.75 | -345,336 | 9/30/20 |
| Wasatch Global Investors Inc | 7,108,935 | 5.03 | 355,792 | 9/30/20 |
| State Street Global Advisors (US) | 7,025,167 | 4.97 | 536,249 | 9/30/20 |
| Bellevue Asset Management AG | 3,850,000 | 2.72 | -- | 9/30/20 |
| Two Sigma Investments, LP | 3,143,165 | 2.22 | -85,025 | 9/30/20 |
| Credit Suisse Asset Management | 2,866,439 | 2.03 | 155,400 | 9/30/20 |
| Dimensional Fund Advisors, L.P. | 2,293,798 | 1.62 | 35,910 | 9/30/20 |
| Geode Capital Management, L.L.C. | 1,758,834 | 1.24 | -13,668 | 9/30/20 |
Top Holders: Mutual Funds
| Fund | Shares Held | % O/S | Share Change | Filing Date |
|---|---|---|---|---|
| SPDR S&P Biotech ETF | 4,827,108 | 3.41 | 200,424 | 10/31/20 |
| BB Biotech Fd | 3,850,000 | 2.72 | -- | 9/30/20 |
| Vanguard Total Stock Market Index Fund | 3,190,907 | 2.26 | 21,263 | 10/31/20 |
| Credit Suisse (Lux) Digital Health Equity Fund | 2,800,000 | 1.98 | -- | 9/30/20 |
| Wasatch Ultra Growth Fund | 2,443,267 | 1.73 | 351,618 | 9/30/20 |
| iShares Russell 2000 ETF | 2,439,408 | 1.72 | 82,260 | 10/31/20 |
| Vanguard Extended Market Index Fund | 1,521,773 | 1.08 | -141,017 | 10/31/20 |
| Wasatch Small Cap Growth Fund | 1,474,647 | 1.04 | 50,476 | 9/30/20 |
| iShares NASDAQ Biotechnology ETF | 1,387,492 | 0.98 | 46,982 | 10/31/20 |
| Vanguard Small-Cap Index Fund | 1,311,676 | 0.93 | -5,690 | 10/31/20 |
* Insider values reflect direct beneficial ownership.
Copyright Refinitiv